Conflict of interest statement
Dr Brannan receives a 10% portion of royalties for the sale of AridolTM / OsmohalerTM that are paid to his prior employer, Royal Prince Alfred Hospital. He holds a minimum number shares in the manufacturer Pharmaxis Ltd. In the past has acted as a consultant to Pharmaxis Ltd and the Nth American distributor of AridolTM, Methapharm Pty Ltd